OPKO Health, Inc. (NASDAQ:OPK) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Third Quarter of 2024 Financial Results Conference Call. All participants will be in listen-only mode.
Opko Health Inc. (OPK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 48,706,640 | $72,572,894 | +10% | 1.18% |
| 2. | Citadel Investment Group Ken Griffin | 2,501,674 | $3,727,494 | +627% | 0% |
| 3. | Millennium Management Israel Englander | 2,476,144 | $3,689,455 | +97% | 0% |
| 4. | 2,151,700 | $3,206,033 | -3% | 0.05% | |
| 5. | 1,300,000 | $1,937,000 | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.62 | 100,000 | 211,612,405 | 2024-11-14 | Filing | ||
| $1.50 | 280,183 | 211,512,405 | 2024-11-08 | Filing | ||
| $1.27 | 770 | 211,232,222 | 2024-05-23 | Filing | ||
| $1.27 | 99,230 | 211,231,452 | 2024-05-23 | Filing | ||
| $1.29 | 163,997 | 211,132,222 | 2024-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.07 | 112,975 | Officer | 161,293 | 2017-03-14 | Filing | |
| $9.85 | 3,000 | Director | 284,088 | 2016-05-13 | Filing | |
| $9.84 | 5,616 | Director | 287,088 | 2016-05-13 | Filing | |
| $9.84 | 900 | Director | 292,704 | 2016-05-13 | Filing | |
| $9.83 | 4,000 | Director | 293,604 | 2016-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 39,751,293 | $60,024,452 | 0% | |
| 2. | 36,965,429 | $55,817,798 | 0% | |
| 3. | 20,750,000 | $20,374,426 | 0.06% | |
| 4. | 14,000,000 | $18,534,932 | 6.04% | |
| 5. | 9,719,368 | $14,677,921 | 0% |
News See All
OPKO Health, Inc. (NASDAQ:OPK) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11577 EPS, expectations were $-0.09. OPKO Health, Inc.
OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript
OPKO Health, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. OPKO Health, Inc.
OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the OPKO Health Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
5 Best High Risk Penny Stocks to Buy Now
Ranking 5th in our list of the best high risk penny stocks is Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharma company working on treatments in immunology, inflammation, and oncology segments.
OPKO Health, Inc. (NASDAQ:OPK) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
OPKO Health, Inc. (NASDAQ:OPK) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the OPKO Health First Quarter 2023 Financial Results Conference Call. . Please note, this event is being recorded.
Billionaire Hedge Funds
